Fluomizin Uses, Dosage, Side Effects and more
Fluomizin (PEG-ahGH) is a recombinant form of human growth hormone that has been modified using Ambrx’s patented ReCODE™ technology to achieve precise spatial positioning of the site of polyethylene glycol (PEG) attachment to human growth hormone, by biosynthetic incorporation of a chemically unique amino acid (ahGH). Fluomizin has improved pharmacological properties, which should allow less frequent administration than the daily dosing regimen of currently available growth hormones.
| Attribute | Details |
|---|---|
| Trade Name | Fluomizin |
| Generic | ARX201 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | Kora Healthcare |
| Available Country | United Kingdom, Portugal, Switzerland |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in growth hormone deficiencies/abnormalities.
